Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer Stock: Assessing Upside Potential After Its Q3 Earnings
08:30am, Tuesday, 12'th Nov 2024
Bayer faces significant risks from litigation and poor M&As, but its current low valuation presents a potential long-term upside, especially post-2025. Despite recent challenges and a dividend cut, Ba
Bayer Stock Slumps on Outlook Cut
07:40am, Tuesday, 12'th Nov 2024
Bayer shares are falling 11% in German trading after the pharmaceuticals and crop science conglomerate reduced its full-year earnings target and warned of likely lower profit next year amid a tough ag
Bayer's stock slumps after warning on crop-sciences unit
07:08am, Tuesday, 12'th Nov 2024
Bayer's stock slumped on Tuesday as the German giant gave a profit warning on agricultural demand.
Bayer cuts FY operating earnings outlook on weak agriculture markets
01:47am, Tuesday, 12'th Nov 2024
Bayer on Tuesday lowered its full-year operating earnings guidance, citing weaker agricultural markets in Latin America.
Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint
10:17am, Wednesday, 30'th Oct 2024
BASEL, Switzerland--(BUSINESS WIRE)--Bayer has launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in par
Bayer Seeks Approval for Elinzanetant for Vasomotor Symptoms in EU
10:51am, Wednesday, 16'th Oct 2024
BAYRY submits an application seeking EMA approval of elinzanetant for treating hot flashes associated with menopause or adjuvant endocrine therapy.
Bayer submits EU marketing application for menopause relief drug
03:34am, Tuesday, 15'th Oct 2024
Bayer on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause relief drug elinzanetant.
Bayer applies for third indication of Nubeqa in EU
04:20am, Monday, 14'th Oct 2024
Bayer said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with androgen deprivation therapy.
Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU
04:00am, Monday, 14'th Oct 2024
ORION CORPORATION INVESTOR NEWS 14 OCTOBER 2024 at 11.00 EEST Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU Orion's collaborat
Bayer must pay $78 mln in latest Roundup cancer trial, jury finds
04:30pm, Thursday, 10'th Oct 2024
Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.
Bayer shares down 7% after U.S. court says it will review Monsanto case
08:22am, Wednesday, 09'th Oct 2024
Shares of German life sciences company Bayer fell more than 7% on Wednesday, after a U.S. court said it would review a case alleging that exposure products made by the company's Monsanto unit harmed i
Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer
05:05am, Tuesday, 08'th Oct 2024
Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer have been highlighted in this Industry Outlook article.
5 Large Drug Stocks to Watch From a Thriving Industry
11:00am, Monday, 07'th Oct 2024
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN), Pfizer (PFE), Sanofi (SNY) and Bayer (BAYRY) are wo
Bayer Reports Positive Safety Data on Parkinson's Disease Drug
03:50pm, Monday, 30'th Sep 2024
BAYRY's experimental Parkinson's disease drug continues to show a favorable safety profile in all 12 participants in the trial's high and low-dose cohorts at 24 months.
MustGrow Biologics CEO discusses commercial expansion, Bayer partnership - ICYMI
09:41am, Saturday, 28'th Sep 2024
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) CEO Corey Giasson joined Proactive to chat about the company's transition to commercialization from its R&D focus. He noted the commercialization of
